The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro (2020)
- Authors:
- Autor USP: SOGAYAR, MARI CLEIDE - IQ
- Unidade: IQ
- DOI: 10.1097/CMR.0000000000000650
- Subjects: MELANOMA; EXPRESSÃO GÊNICA; METALOPROTEINASES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2020
- Source:
- Título do periódico: Melanoma Research
- ISSN: 0960-8931
- Volume/Número/Paginação/Ano: v. 30, n. 3, p. 223-234, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
JACOMASSO, Thiago et al. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, v. 30, n. 3, p. 223-234, 2020Tradução . . Disponível em: https://doi.org/10.1097/CMR.0000000000000650. Acesso em: 03 jun. 2024. -
APA
Jacomasso, T., Ribas, H. T., Lima, M. T., Konig, M. S., Trindade, E. da S., Martinez, G. R., et al. (2020). The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, 30( 3), 223-234. doi:10.1097/CMR.0000000000000650 -
NLM
Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1097/CMR.0000000000000650 -
Vancouver
Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1097/CMR.0000000000000650 - Role of polyoma t antigens in balb-c/3t3 cells growth control deregulation
- Further characterization of balb-3t3 transfectants bearing polyoma t antigen genes
- Controle e subversao da proliferacao
- Glucocorticoid-regulated gene in transformed to normal phenotypic reversion
- T antigens role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle t
- Cdna cloning and expression of growth control genes
- Fibroblast growth factor and camp induce the expression of fos and jun proto-oncogenes in pc12 cells
- Molecular bases for the transformed to normal phenotypic reversion induced by glucocorticoid hormoners in rat glioma
- Cloning of differentially expressed genes involved glucocorticoid-induced phenotypic reversion of c6 glioma cells
- Hydrazine derivative - induced proliferation superimposed on citotoxity in cultured moused fibroblasts
Informações sobre o DOI: 10.1097/CMR.0000000000000650 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
